DLD Asset Management’s Immunomedics Inc IMMU Stock Holding History

DLD Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-47,500	Closed	-$1M	–	114
2019 Q4	$1M	Buy	+47,500	New	+$838K	0.05%	76
2019 Q1	–	Sell	-3,453,700	Closed	-$49.3M	–	113
2018 Q4	$49.3M	Buy	3,453,700 +50,700	+1%	+$1.01M	3.38%	7
2018 Q3	$70.9M	Buy	3,403,000 +720,900	+27%	+$17.1M	3.51%	6
2018 Q2	$63.5M	Buy	2,682,100 +332,800	+14%	+$6.69M	4.78%	4
2018 Q1	$34.3M	Buy	2,349,300 +881,000	+60%	+$14.4M	3.1%	8
2017 Q4	$23.7M	Buy	1,468,300 +846,500	+136%	+$9.99M	1.72%	17
2017 Q3	$8.69M	Buy	621,800 +174,600	+39%	+$1.74M	0.86%	25
2017 Q2	$3.95M	Buy	+447,200	New	+$3.14M	0.51%	32

DLD Asset Management's IMMU Position: Q4 2020 in Review

DLD Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 700,000 shares — an estimated $59.5M sold.

DLD Asset Management first reported a position in IMMU in Q4 2019 and held it in 2 quarters. The position peaked at $59.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

DLD Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
DLD Asset Management sold 700,000 Immunomedics Inc shares in Q4 2020, an estimated $59.5M.
DLD Asset Management first reported a position in Immunomedics Inc in Q4 2019 and held it in 2 quarters.
DLD Asset Management's Immunomedics Inc position peaked at $59.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on DLD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.